BRIEF published on 07/08/2024 at 16:20, 1 year 8 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million Acquisition Investment Biotech Immuno-oncology QARZIBA®
PRESS RELEASE published on 07/08/2024 at 16:15, 1 year 8 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
Published on 03/26/2026 at 13:00, 3 hours 21 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 3 hours 21 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 3 hours 22 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 3 hours 36 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 15:25, 56 minutes ago Duck Creek Loss Control Named 2026 Insurance Luminary Finalist by PropertyCasualty360
Published on 03/26/2026 at 15:23, 57 minutes ago Sartorius AG - Resolutions of the Annual General Meeting
Published on 03/26/2026 at 15:05, 1 hour 16 minutes ago JOY GROUP Announces 2025 Financial Results, Revenue Surpasses US$620M
Published on 03/26/2026 at 15:01, 1 hour 19 minutes ago EQS-Adhoc: CENIT AG decides to switch from the Regulated Market (Prime Standard) to the Scale Segment of the Frankfurt Stock Exchange
Published on 03/26/2026 at 15:00, 1 hour 21 minutes ago OLB’s financial performance remains at a consistently high level
Published on 03/26/2026 at 07:30, 8 hours 51 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 21 hours 50 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 22 hours 36 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
